We are live on ! Find out more
NVAX icon

Novavax

175 hedge funds and large institutions have $1.15B invested in Novavax in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 39 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 39

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

1% more funds holding

Funds holding: 173175 (+2)

23% less call options, than puts

Call options by funds: $6.02M | Put options by funds: $7.86M

33% less capital invested

Capital invested by funds: $1.71B → $1.15B (-$567M)

Holders
175
Holders Change
+2
Holders Change %
+1.16%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
31
Increased
77
Reduced
39
Closed
27
Calls
$6.02M
Puts
$7.86M
Net Calls
-$1.83M
Net Calls Change
-$6.34M
Name Holding Trade Value Shares
Change
Change in
Stake
QI
201
QS Investors
New York
-$1K -2 Closed

NVAX Hedge Fund Activity: Q1 2016 in Review

175 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2016, worth a combined $1.15B — down 33% from $1.71B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new NVAX positions and 27 closed out — a net gain of 4 holders — while 77 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $20.6M. The largest seller was First Trust Advisors, cutting an estimated $47.5M.

  • 175 institutional investors held Novavax (NVAX) as of Q1 2016, up from 173 in Q4 2015.
  • Funds reported $1.15B of Novavax stock for Q1 2016, down 33% quarter-over-quarter.
  • 31 funds opened new Novavax positions in Q1 2016 and 27 closed out, a net change of +4 holders.
  • The largest Novavax buyer in Q1 2016 was Wellington Management Group, an estimated $20.6M added.
  • The largest Novavax seller in Q1 2016 was First Trust Advisors, an estimated $47.5M sold.

Based on aggregated 13F filings for Q1 2016.